Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Fennec Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.

Get FENC alerts

About Rostislav Raykov

Rostislav Raykov is recorded as CEO at Fennec Pharmaceuticals Inc. (FENC). Fennec Pharmaceuticals Inc. reported in an 8-K filed April 28, 2026 that Rostislav Raykov retired as Board of Directors, effective April 27, 2026. The proxy statement of Fennec Pharmaceuticals Inc. reports total compensation of $2,124,216 for Rostislav Raykov in fiscal 2020, including a base salary of $430,000. Disclosed compensation is on record for 3 fiscal years. Rostislav Raykov has spoken on 2 earnings calls across 1 company, most recently for Fennec Pharmaceuticals Inc. on May 14, 2024. Fennec Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fennec Pharmaceuticals Inc. includes Adrian Haigh (COO), Jeff Hackman (Board Member) and Jeffrey S. Hackman (Board Member).

“On April 27, 2026, Rostislav Raykov notified Fennec Pharmaceuticals Inc. (the "Company") of his desire to retire from the Company's Board of Directors (the "Board") and that he will not stand for re-election at the Company's 2026 annual meeting of shareholders (the "Annual Meeting").”
Fennec Pharmaceuticals Inc. Form 8-K, filed April 28, 2026 · Read the filing

Rostislav Raykov on recent calls

“On today's call, we will detail our first quarter financial results, all of which were outlined in our earnings press release issued this morning prior to this call.”
CEO, Fennec Pharmaceuticals Inc. Q1 FY2024 Earnings Call ·
“We appreciate this time you’re giving us today. We’ll be discussing the market opportunity ahead of us, our recent progress as we have achieved many significant milestones over the past several months.”
CEO, Fennec Pharmaceuticals Inc. Q1 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Fennec Pharmaceuticals Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Fennec Pharmaceuticals Inc. (FENC) $430,000 $2,124,216
2019 Fennec Pharmaceuticals Inc. (FENC) $488,692 $1,476,536
2018 Fennec Pharmaceuticals Inc. (FENC) $350,000 $1,072,261

Recent activity